Agilera Pharma
Radiopharmaceutical CDMO in Norway, handling development to commercial supply for drug developers and research groups
Highlights
- Young companyFounded 2021
- Hiring1 open role
- New on EvolcAdded 2026-10-28
About Agilera Pharma
Agilera Pharma is a contract development and manufacturing organisation (CDMO) for radiopharmaceuticals. It covers the full development chain for new radiopharmaceutical product candidates, from the preclinical phase to commercial production and global distribution.
Its customers are research groups and pharmaceutical developers that need to turn research into commercially viable products. The company is approved as a manufacturer in the USA, Japan, Europe, Latin America, China and a number of other countries, and describes a global distribution network for delivering radiopharmaceuticals to patients.
Agilera was founded in 2021 and is headquartered in Kjeller, Norway. It was spun out of the Institute for Energy Technology (IFE). A press release on the homepage announces that PharmaLogic has completed the acquisition of a majority stake in Agilera Pharma AS from IFE and PharmaLogic Holdings Corp. Open positions listed on the careers page include production operator roles in Kjeller, and the company's teams cover radiochemistry, analytical chemistry, radiation protection and quality assurance with Qualified Persons under EU GMP and GDP rules.
Product: Contract development and commercial manufacturing of radiopharmaceuticals, with global distribution, from preclinical phase to commercial supply.
Jobs at Agilera Pharma (1)
Agilera Pharma is hiring for one role in manufacturing, based in Kjeller.
Produksjonsmedarbeider / Operatør
Young companyNew on Evolc
More biotech & pharma companies
Alginor
Harvests and biorefines Norwegian kelp into formaldehyde-free ingredients for pharma and nutraceutical manufacturersNew on EvolcAlgipharma
Develops alginate-based drug delivery technologies and therapeutics for pharmaceutical and healthcare applicationsNew on EvolcAmicoat
Antimicrobial peptide coating technology for medical device makers aiming to reduce hospital-acquired infectionsNew on EvolcArctic Bioscience
Biotech developing marine membrane lipid ingredients from herring roe for pharma and nutraceutical buyersNew on EvolcArcticzymes
Enzyme supplier for molecular research, diagnostics and biomanufacturing, including cold-adapted and salt-active nucleasesNew on EvolcArtbio
Develops alpha radioligand cancer therapies for patients; lead prostate cancer candidate AB001 is in Phase 1 trialsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- PHP
- WordPress
- jQuery